SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-122631
Filing Date
2016-05-23
Accepted
2016-05-23 16:36:54
Documents
1
Period of Report
2016-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3987
  Complete submission text file 0001209191-16-122631.txt   5407
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Issuer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NEW LEAF VENTURE PARTNERS 1200 PARK PLACE, SUITE 300 SAN MATEO CA 94043
Business Address
Dybbs Michael (Reporting) CIK: 0001601264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37601 | Film No.: 161669500